Michalina Kupsik, MD
Surgical Oncology · Spokane, WANPI 1043657422
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,224 of the $5,112 with a category attached, or 63.1%. It is spread thinly across 34 manufacturers, the largest accounting for just 20.7%. Reporting peaked in 2024 at $2,658 and has fallen 70.6% since, to $780 in 2025. That places this record below the midpoint for surgical oncology clinicians in WA, where the typical reported total is $5,112.
Across 104 payments — averaging $49.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elucent Medical$1K
- Medtronic$935
- Myriad Genetic Laboratories, Inc.$513
- Endomagnetics Ltd$490
- AstraZeneca$375
- KUB Technologies Inc.$296
- plus $1K from 28 others
What the payments were for
- Travel & lodging$1,67533%
- Food & beverage$3,22463%
- Education$261%
- Entertainment$1874%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elucent Medical | 2 | $1,057 |
| Medtronic | 19 | $935 |
| Myriad Genetic Laboratories, Inc. | 20 | $513 |
| Endomagnetics Ltd | 4 | $490 |
| AstraZeneca(2 entities) | 11 | $375 |
| KUB Technologies Inc. | 2 | $296 |
| Merit Medical Systems Inc | 4 | $255 |
| Novartis | 6 | $132 |
| Gilead | 1 | $125 |
| Koya Medical, Inc. | 1 | $108 |
| Pacira Pharmaceuticals Incorporated | 1 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| Johnson & Johnson | 5 | $71 |
| Incyte Corporation | 2 | $51 |
| GE HealthCare | 1 | $48 |
| Blueprint Medicines Corporation | 3 | $48 |
| Merck | 2 | $48 |
| Stryker | 1 | $40 |
| Sobi, Inc | 1 | $31 |
| Genentech USA, Inc. | 1 | $29 |
| Boehringer Ingelheim | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Fennec Pharmaceuticals, Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $24 |
| Molli Surgical (US) Inc | 1 | $24 |
| Array Biopharma Inc | 1 | $22 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Pharmaand GmbH | 1 | $18 |
| Acrotech Biopharma Inc. | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Dendreon Pharmaceuticals LLC | 1 | $17 |
| Mirati Therapeutics, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Magseed$480
- Magtrace$480
- PlasmaBlade$406
- Mozart$296
- Koya Medical$217
- Dayspring$217
- Trodelvy$125
- LYNPARZA$121
- Savi SCOUT$120
How this compares
$5,112 in reported general payments places this provider in the 50th percentile of 31 surgical oncology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 19 | $98 |
| Gabapentin | 27 | $59 |
| Oxycodone Hcl | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Spokane
- Jennifer PaskoSpokane$6K
- Maryam ParvizSpokane$3K
- Rebecca KirschnerSpokane$2K
- Jessemae WelshSpokane$912
- Ryan HolbrookSpokane$88
- Deborah MartinezSpokane$38
- Cary KaufmanBellingham$171K
- Flavio RochaSeattle$27K
- Evan OngSeattle$18K
- Benjamin AndersonSeattle$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.